Compare CCTG & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CCTG | PPCB |
|---|---|---|
| Founded | 1993 | 2007 |
| Country | Hong Kong | Australia |
| Employees | N/A | 2 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 1.9M |
| IPO Year | 2022 | N/A |
| Metric | CCTG | PPCB |
|---|---|---|
| Price | $0.59 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.4K | ★ 6.3M |
| Earning Date | 12-23-2025 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.10 |
| 52 Week High | $2.61 | $10.69 |
| Indicator | CCTG | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 44.06 |
| Support Level | $0.39 | N/A |
| Resistance Level | $0.77 | $0.13 |
| Average True Range (ATR) | 0.05 | 0.02 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 76.32 | 21.08 |
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.